WILD INDIGO: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Wild indigo is an herb. The root is used to make medicine. Sometimes the sap of wild indigo is used as a dye.

Wild indigo is used for infections such as diphtheria, influenza (flu), the common cold, other upper respiratory tract infections, malaria, typhoid, and many other conditions, but there is no good scientific evidence to support these uses.

Do not confuse wild indigo with other plants that are often referred to as indigo. Also, don't confuse wild indigo with indigo carmine. Indigo carmine is a dye that is created in a lab and is used for many industrial purposes.

How does it work ?

There isn't enough information to know how wild indigo works.

Uses & Effectiveness

Insufficient Evidence for

Common cold.
Cold sores.
Low white blood cell count (leukopenia).
Swelling (inflammation) of the nasal cavity and sinuses (rhinosinusitis).
Swelling (inflammation) of the tonsils (tonsillitis).
Diphtheria.
Influenza (flu).
Malaria.
Typhoid fever.
Scarlet fever.
Sore throat.
Swelling of the mouth and throat.
Fever.
Crohn disease.
Ulcers.
Wounds.
Sore and painful nipples.
Other conditions.

More evidence is needed to rate the effectiveness of wild indigo for these uses.

Side Effects

When taken by mouth: Wild indigo is LIKELY UNSAFE when taken by mouth long-term or in large doses such as 30 grams or more. Large doses can cause vomiting, diarrhea, other intestinal problems, and spasms. There isn't enough reliable information to know if wild indigo is safe when used in lower doses.

When applied to the skin: There isn't enough reliable information to know if wild indigo is safe or what the side effects might be.

Special Precautions and Warnings

Pregnancy and breast-feeding: Wild indigo is LIKELY UNSAFE when taken by mouth or applied to the skin. Avoid use.

Stomach or intestinal problems: Wild indigo can be especially harmful to people with stomach or intestinal problems. Avoid use.

Interactions

We currently have no information for WILD INDIGO overview.

Dosing

The appropriate dose of wild indigo depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for wild indigo. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

View References

REFERENCES:

Bahmer, F. A. and Schafer, J. [Treatment of atopic dermatitis with borage seed oil (Glandol)--a time series analytic study]. Kinderarztl.Prax. 1992;60(7):199-202. View abstract.

Bard, J. M., Luc, G., Jude, B., Bordet, J. C., Lacroix, B., Bonte, J. P., Parra, H. J., and Duriez, P. A therapeutic dosage (3 g/day) of borage oil supplementation has no effect on platelet aggregation in healthy volunteers. Fundam.Clin.Pharmacol. 1997;11(2):143-144. View abstract.

Barre, D. E. and Holub, B. J. The effect of borage oil consumption on the composition of individual phospholipids in human platelets. Lipids 1992;27(5):315-320. View abstract.

Borrek, S., Hildebrandt, A., and Forster, J. [Gamma-linolenic-acid-rich borage seed oil capsules in children with atopic dermatitis. A placebo-controlled double-blind study]. Klin.Padiatr. 1997;209(3):100-104. View abstract.

Christophe, A., Robberecht, E., Franckx, H., De Baets, F., and van de, Pas M. Effect of administration of gamma-linolenic acid on the fatty acid composition of serum phospholipids and cholesteryl esters in patients with cystic fibrosis. Ann.Nutr Metab 1994;38(1):40-47. View abstract.

Demmelmair, H., Feldl, F., Horvath, I., Niederland, T., Ruszinko, V., Raederstorff, D., De Min, C., Muggli, R., and Koletzko, B. Influence of formulas with borage oil or borage oil plus fish oil on the arachidonic acid status in premature infants. Lipids 2001;36(6):555-566. View abstract.

Dooper, M. M., van Riel, B., Graus, Y. M., and M'Rabet, L. Dihomo-gamma-linolenic acid inhibits tumour necrosis factor-alpha production by human leucocytes independently of cyclooxygenase activity. Immunology 2003;110(3):348-357. View abstract.

Harbige, L. S. and Fisher, B. A. Dietary fatty acid modulation of mucosally-induced tolerogenic immune responses. Proc Nutr Soc 2001;60(4):449-456. View abstract.

Kapoor, R. and Klimaszewski, A. Efficacy of borage oil in patients with atopic eczema. Br J Dermatol 2000;143(1):200-201. View abstract.

Martens-Lobenhoffer, J. and Meyer, F. P. Pharmacokinetic data of gamma-linolenic acid in healthy volunteers after the administration of evening primrose oil (Epogam). Int.J Clin Pharmacol Ther. 1998;36(7):363-366. View abstract.

Palombo, J. D., DeMichele, S. J., Boyce, P. J., Lydon, E. E., Liu, J. W., Huang, Y. S., Forse, R. A., Mizgerd, J. P., and Bistrian, B. R. Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats. Crit Care Med 1999;27(9):1908-1915. View abstract.

Pittler, M. H., Verster, J. C., and Ernst, E. Interventions for preventing or treating alcohol hangover: systematic review of randomised controlled trials. BMJ 12-24-2005;331(7531):1515-1518. View abstract.

Rosenstein, E. D., Kushner, L. J., Kramer, N., and Kazandjian, G. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukot.Essent.Fatty Acids 2003;68(3):213-218. View abstract.

Rossetti, R. G., Seiler, C. M., DeLuca, P., Laposata, M., and Zurier, R. B. Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation. J Leukoc.Biol 1997;62(4):438-443. View abstract.

Tollesson, A. and Frithz, A. Transepidermal water loss and water content in the stratum corneum in infantile seborrhoeic dermatitis. Acta Derm.Venereol 1993;73(1):18-20. View abstract.

van Gool, C. J., Thijs, C., Henquet, C. J., van Houwelingen, A. C., Dagnelie, P. C., Schrander, J., Menheere, P. P., and van den brandt, P. A. Gamma-linolenic acid supplementation for prophylaxis of atopic dermatitis--a randomized controlled trial in infants at high familial risk. Am J Clin Nutr 2003;77(4):943-951. View abstract.

Westman, E. C., Yancy, W. S., Jr., Olsen, M. K., Dudley, T., and Guyton, J. R. Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses. Int J Cardiol. 6-16-2006;110(2):212-216. View abstract.

Ziboh, V. A. and Fletcher, M. P. Dose-response effects of dietary gamma-linolenic acid-enriched oils on human polymorphonuclear-neutrophil biosynthesis of leukotriene B4. Am J Clin Nutr 1992;55(1):39-45. View abstract.

Ziboh, V. A., Naguwa, S., Vang, K., Wineinger, J., Morrissey, B. M., Watnik, M., and Gershwin, M. E. Suppression of leukotriene B4 generation by ex-vivo neutrophils isolated from asthma patients on dietary supplementation with gammalinolenic acid-containing borage oil: possible implication in asthma. Clin.Dev.Immunol. 2004;11(1):13-21. View abstract.

Bamford JTM, Ray S, Musekiwa A, et al. Oral evening primrose oil and borage oil for eczema. Cochrane Database of Systematic Reviews 2013,4: CD004416.

Bandoniene D, Murkovic M. The detection of radical scavenging compounds in crude extract of borage (Borago officinalis L.) by using an on-line HPLC-DPPH method. J Biochem Biophys Methods 2002;53:45-9. View abstract.

Barre DE. Potential of evening primrose, borage, black currant, and fungal oils in human health. Ann Nutr Metab 2001;45:47-57. View abstract.

Classen, B., Csavas, M., Borbas, A., Dingermann, T., and Zundorf, I. Monoclonal Antibodies against an Arabinogalactan-Protein from Pressed Juice of Echinacea purpurea. Planta Med. 2004;70(9):861-865. View abstract.

Classen, B., Thude, S., Blaschek, W., Wack, M., and Bodinet, C. Immunomodulatory effects of arabinogalactan-proteins from Baptisia and Echinacea. Phytomedicine. 2006;13(9-10):688-694. View abstract.

Dowlatshahi, K., Jokich, P. M., Schmidt, R., Bibbo, M., and Dawson, P. J. Cytologic diagnosis of occult breast lesions using stereotaxic needle aspiration. A preliminary report. Arch Surg 1987;122(11):1343-1346. View abstract.

Egert, D. and Beuscher, N. Studies on antigen specifity of immunoreactive arabinogalactan proteins extracted from Baptisia tinctoria and Echinacea purpurea. Planta Med. 1992;58(2):163-165. View abstract.

Forth, H. and Beuscher, N. Beeinflussing der Häufigkeit banaler Erkältungsinfekte durch Esberitox. Zeitschrift für Allgemeinmedizin [Effect on the frequency of banal cold infections by esberitox]. ZFA.(Stuttgart.) 11-20-1981;57(32):2272-2275. View abstract.

Gerhardt, P. [Influence of an unspecific stimulation therapy using Esberitox on leukopoiesis during the use of ionizing radiation]. Strahlentherapie. 1972;143(5):549-558. View abstract.

Guo, R., Canter, P. H., and Ernst, E. Herbal medicines for the treatment of rhinosinusitis: a systematic review. Otolaryngol.Head Neck Surg. 2006;135(4):496-506. View abstract.

Guo, R., Pittler, M. H., and Ernst, E. Herbal medicines for the treatment of COPD: a systematic review. Eur.Respir.J 2006;28(2):330-338. View abstract.

Hauke, W., Kohler, G., Henneicke-von Zepelin, H. H., and Freudenstein, J. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study. Chemotherapy 2002;48(5):259-266. View abstract.

HELBIG, G. [Nonspecific therapy with irritants for infection prophylaxis. A study of the therapeutic effect of Esberitox]. Med Klin. 9-1-1961;56:1512-1514. View abstract.

Hentschel C, Zeppelin HH Kohnen R Kohler G Wustenberg P Ernst E. Clinical efficacy of Esberitox in common cold - results of a (GCP) randomised double-blind placebo-controlled multicenter study. Focus on Alternative and Complementary Ther 1997;2(4):189.

Hentschel, C., Schnitker, J., Kohnen, R., Kohler, G., Lindhauer, I., and Henneicke-von Zepelin, H. H. [Phytotherapeutic drugs for the common cold. Results of a randomized controlled double-blind study]. MMW.Fortschr.Med. 3-2-2000;142(9):46. View abstract.

HOFFMANN, R. [Esberitox, an oral remedy for non-specific therapeutic irritation in infectious inflammation]. Ther Ggw. 1952;91(5):186. View abstract.

Ikeda, T., Jinno, H., Fujii, H., and Kitajima, M. Recent development of sentinel lymph node biopsy for breast cancer in Japan. Asian J Surg 2004;27(4):275-278. View abstract.

Imoto, S., Fukukita, H., Murakami, K., Ikeda, H., and Moriyama, N. Pilot study on sentinel node biopsy in breast cancer. J Surg Oncol 2000;73(3):130-133. View abstract.

JOHNE, H. O. and SPERR, A. [Experimental and clinical experiences with stimulation therapy with gluco-lipopolypeptide complexes (esberitox) in dermatology]. Medizinische. 8-25-1956;7(33-34):1145-1147. View abstract.

Kindzel'skii, L. P., Zlochevskaia, L. L., Tsyganok, T. V., and Shabaeva, M. M. [The effect of natural immunomodulators on the lymphocytic natural killer activity in patients with malignant lymphoproliferative diseases]. Lik.Sprava. 1995;(1-2):146-148. View abstract.

Kleinschmidt, H. [An experiment to decrease susceptibility to infections in young children with Esberitox]. Ther Ggw. 1965;104(9):1258-1262. View abstract.

Kohler, G., Bodinet, C., and Freudenstein, J. [Pharmacodynamic effects and clinical effectiveness of a combination of herbal substances comprised of Cone Flower, Wild Indigo and White Cedar]. Wien.Med Wochenschr. 2002;152(15-16):393-397. View abstract.

Liesen H, Kleiter K Mucke S Order U Widenmayer W Riedel H. Leucocytes and lymphocyte subpopulations in players of the German Olympic games in 1988. Deutsch Zeitschrift fur Soprtmedizin 1989;1-10.

Naser, B., Lund, B., Henneicke-von Zepelin, H. H., Kohler, G., Lehmacher, W., and Scaglione, F. A randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common cold. Phytomedicine. 2005;12(10):715-722. View abstract.

Pohl, P. [On the therapy of irradiation-induced leukopenia with Esberitox]. Med.Klin. 1969;64(35):1546-1547. View abstract.

Pohl, P. [Treatment of radiation-induced leukopenia with Esberitox]. Ther Ggw. 1970;109(6):902-906. View abstract.

Ragosch, V., Hundertmark, S., Hopp, H., Opri, F., and Weitzel, H. K. [Insulin-like-growth-factor-binding-protein 1 (IGFBP-1) and fetal fibronectin in diagnosis of premature rupture of fetal membranes]. Geburtshilfe Frauenheilkd. 1996;56(6):291-296. View abstract.

Reitz HD. [Immunomodulation with phytotherapeutic agents: a scientific study on the example of Esberitox]. Notabene medici 1990;20:362-366.

Roxas, M. and Jurenka, J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern.Med Rev. 2007;12(1):25-48. View abstract.

Sartor, K. J. [Efficacy of Esberitox in the treatment of radiation-induced leukopenia]. Ther Ggw. 1972;111(8):1147-1150. View abstract.

SCHWARZ, F. K. [Peroral change of general reaction to infections by esberitox]. Med Klin.(Munich) 10-3-1952;47(40):1320-1322. View abstract.

Stolze H and Forth H. [A treatment with antibiotics can be optimized by additional immunostimulation]. Der Kassenartz 1983;23:43-48.

Vomel, T. [Effect of a plant immunostimulant on phagocytosis of erythrocytes by the reticulohistiocytary system of isolated perfused rat liver]. Arzneimittelforschung. 1985;35(9):1437-1439. View abstract.

von Blumroeder W-O. [Angina lacunaris. An investigation on how to stimulate the endogenous defense system] (German). Z.Allg.Med. 1985;61:271-273.

VON OETTINGEN, E. N. [Acute diseases of the ear and neck; contribution to the use of esberitox]. Ther Ggw. 1954;93(4):152-153. View abstract.

Vorberg G. For colds, stimulate the nonspecific immune system. Arztliche Praxis 1984;6:97-98.

Wack, M., Classen, B., and Blaschek, W. An acidic arabinogalactan-protein from the roots of Baptisia tinctoria. Planta Med. 2005;71(9):814-818. View abstract.

Wagner, H. and Jurcic, K. [Immunologic studies of plant combination preparations. In-vitro and in-vivo studies on the stimulation of phagocytosis]. Arzneimittelforschung. 1991;41(10):1072-1076. View abstract.

Wagner, H., Horhammer, L., Budweg, W., Major, A., and Farkas, L. [Investigation of the glycosides from Baptisia tinctoria. 3. Synthesis of pseudobaptisins]. Chem.Ber. 1969;102(9):3006-3008. View abstract.

Wagner, H., Proksch, A., Riess-Maurer, I., Vollmar, A., Odenthal, S., Stuppner, H., Jurcic, K., Le Turdu, M., and Fang, J. N. [Immunostimulating action of polysaccharides (heteroglycans) from higher plants]. Arzneimittelforschung 1985;35(7):1069-1075. View abstract.

Wagner, H., Proksch, A., Riess-Maurer, I., Vollmar, A., Odenthal, S., Stuppner, H., Jurcic, K., Le, Turdu M., and Heur, Y. H. [Immunostimulant action of polysaccharides (heteroglycans) from higher plants. Preliminary communication]. Arzneimittelforschung. 1984;34(6):659-661. View abstract.

Wustenberg, P., Henneicke-von Zepelin, H. H., Kohler, G., and Stammwitz, U. Efficacy and mode of action of an immunomodulator herbal preparation containing Echinacea, wild indigo, and white cedar. Adv.Ther 1999;16(1):51-70. View abstract.

Zimmer M. Specific conservative treatment of acute sinusitis in the ENT practice. Therapiewoche 1985;35:4024-4028.

Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract 1999;48:628-35. View abstract.

Bendel R, Bendel V, Renner K, et al. [Additional treatment with Esberitox N in patients with chemo- radiotherapy treatment of advanced breast cancer]. Onkologie. 1989;12 Suppl 3:32-8. View abstract.

Bendel R, Bendel V, Renner K, et al. [Supplementary treatment with Esberitox of female patients undergoing curative adjuvant irradiation following breast cancer]. Strahlenther.Onkol. 1988;164:278-83. View abstract.

Beuscher N, Scheit KH, Bodinet C, Kopanski L. [Immunologically active glycoproteins of Baptisia tinctoria]. Planta Med 1989;55:358-63. View abstract.

Bockhorst H, Gollnick N, Guran S, et al. [Therapy of herpes simplex in practice. Report on the treatment of herpes simplex labialis with Esberitox]. ZFA.(Stuttgart.) 11-20-1982;58:1795-98. View abstract.

Henneicke-von Zepelin H, Hentschel C, Schnitker J, et al. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo-controlled, multicentre study. Curr Med Res Opin 1999;15:214-27. View abstract.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.